Manufacturing ATMPs – moving from approvable to commercial success

KTN will be holding this event, in partnership with the Future Targeted Healthcare Manufacturing Hub, on 18th September at UCL in London. The meeting agenda will focus on the current UK innovation landscape for advanced therapies, in support of enabling gene and cell therapy products to go from approvable to commercially successful. We will also hear about translational research projects in support of manufacturing readiness, in addition to a future looking session regarding key challenges from clinical, regulatory and skills perspectives. The KTN supports the Hub in delivery of this meeting to enable industry and academia engagement and collaboration, and showcasing of the relevant translational research being undertaken by the Hub in collaboration with industry.

We are expecting about 100 delegates on the day from the wider sector. The event is free to attend free event for the community. The agenda will be published soon. Free to attend